Search

Your search keyword '"E. Menegatti"' showing total 440 results

Search Constraints

Start Over You searched for: Author "E. Menegatti" Remove constraint Author: "E. Menegatti"
440 results on '"E. Menegatti"'

Search Results

351. Assay of 1,4-dioxane in commercial cosmetic products by HPLC.

352. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by benzamidine and its bis-, tris- and tetra-derivatives: thermodynamic and molecular modeling study.

353. Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to serine (pro)enzymes: a comparative thermodynamic study.

355. Experience on antineutrophil cytoplasm antibodies and antimyeloperoxidase antibodies in rapidly progressive glomerulonephritis.

356. Binding of the recombinant proteinase inhibitor eglin c, of the soybean Bowman-Birk proteinase inhibitor and of its chymotrypsin and trypsin inhibiting fragments to Leu-proteinase, the leucine specific serine proteinase from spinach (Spinacia oleracea L.) leaves: thermodynamic study.

357. Classic and perinuclear anti-neutrophil cytoplasm antibodies and antimyeloperoxidase antibodies in rapidly progressive glomerulonephritis.

358. Binding of the bovine and porcine pancreatic secretory trypsin inhibitor (Kazal) to human leukocyte elastase: a thermodynamic study.

359. [Hirudin inhibition of human thrombin activity].

360. Binding of the soybean Bowman-Birk proteinase inhibitor and of its chymotrypsin and trypsin inhibiting fragments to bovine alpha-chymotrypsin and bovine beta-trypsin. A thermodynamic study.

361. Bovine trypsinogen activation. A thermodynamic study.

362. X-ray crystal structure of the bovine alpha-chymotrypsin/eglin c complex at 2.6 A resolution.

363. Binding of the bovine basic pancreatic trypsin inhibitor (Kunitz) to human Glu1-, Lys77-, Val442-, and Val561-plasmin: a comparative study.

364. Tumor cell growth inhibition by liposome-encapsulated aromatic polyamidines.

365. Determination of 1,4-dioxane in cosmetic products by high-performance liquid chromatography.

366. Binding of the bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor) to human and bovine factor Xa. A thermodynamic study.

367. Thermodynamic modeling of internal equilibria involved in the activation of trypsinogen.

368. Binding of the bovine basic pancreatic trypsin inhibitor (Kunitz) to the 33,000 Mr and 54,000 Mr species of human urokinase: thermodynamic study.

369. Liposome-associated retinoic acid. Increased in vitro antiproliferative effects on neoplastic cells.

370. Trypsin-pancreatic secretory isoinhibitor A from bovine pancreas (Kazal type). Spectroscopic study on structure and stability.

371. Active-site titration of serine proteinases acting selectively on cationic substrates by N-alpha-carbobenzoxy-L-arginine p-nitrophenyl ester and N-alpha-carbobenzoxy-L-lysine p-nitrophenyl ester; determination of active enzyme concentration.

372. The pH dependence of pre-steady-state and steady-state kinetics for the porcine pancreatic beta-kallikrein-B-catalyzed hydrolysis of N-alpha-carbobenzoxy-L-arginine p-nitrophenyl ester.

373. Preliminary crystallographic data on the complex of bovine alpha-chymotrypsin with the recombinant proteinase inhibitor eglin c from Hirudo medicinalis.

374. pH and temperature effects on the molecular conformation of the porcine pancreatic secretory trypsin inhibitor as detected by hydrogen-1 nuclear magnetic resonance.

375. Binding of the bovine pancreatic secretory trypsin inhibitor (Kazal) to bovine serine (pro)enzymes.

376. Studies on trypsin inhibitors. Part V. Synthesis of the protected octapeptide (sequence 36-43) of porcine pancreatic secretory trypsin inhibitor II (Kazal).

377. Isolation and characterization of a new form of the porcine pancreatic secretory trypsin inhibitor. Biochemical studies and high-resolution 1H-NMR.

378. Interaction between serine (pro)enzymes, and Kazal and Kunitz inhibitors.

379. Primary specificity of ancrod, the coagulating serine proteinase from the Malayan pit viper (Agkistrodon rhodostoma) venom.

380. Catalytic properties of human urinary kallikrein.

381. Trypsin activation. Effect of the Ile-Val dipeptide concentration on Kazal inhibitor binding to bovine trypsinogen.

382. 1H-NMR studies of the structure and stability of the bovine pancreatic secretory trypsin inhibitor.

383. Catalytic properties of bovine alpha-thrombin: a comparative steady-state and pre-steady-state study.

384. Interaction of epidermal growth factor with micelles monitored by photochemically induced dynamic nuclear polarization-1H NMR spectroscopy.

385. Aromatic tetra-amidines: antiproteolytic and antiesterolytic activities towards serine proteinases involved in blood coagulation and clot lysis.

386. Activating effect of the Ile-Val dipeptide on the catalytic properties of bovine trypsinogen.

388. 1H-NMR of reverse micelles. II: Conformational studies of peptides and proteins in the AOT/water/isooctane system.

389. Aromatic tetra-amidines: synthesis of halo-derivatives and their antiproteolytic activity.

390. Tetra-p-amidinophenoxy-propane as a probe of the specificity site of serine proteases.

391. Catalytic properties of serine proteases. 2. Comparison between human urinary kallikrein and human urokinase, bovine beta-trypsin, bovine thrombin, and bovine alpha-chymotrypsin.

392. Binding of the bovine basic pancreatic trypsin inhibitor (Kunitz) to human alpha-, beta- and gamma-thrombin; a kinetic and thermodynamic study.

393. Inhibition of serine proteinases by p-carbethoxyphenyl esters of epsilon-guanidino- and epsilon-amino caproic acid: thermodynamic and molecular modeling study.

394. Transient removal of proflavine inhibition of bovine beta-trypsin by the bovine basic pancreatic trypsin inhibitor (Kunitz). A case for "chronosteric effects".

395. Structure-function relationship for Kunitz and Kazal type trypsin inhibitors.

396. [Tissue response to a new collagen-based preparation (BC I)].

397. Catalytic properties of porcine pancreatic elastase: a steady-state and pre-steady-state study.

398. Binding of the bovine basic pancreatic trypsin inhibitor (Kunitz) to human Lys77-plasmin.

399. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.

400. Binding of the Ile-Val and Val-Val effector dipeptides to the binary adducts of bovine trypsinogen with Kunitz and Kazal inhibitors as well as the acylating agent p-nitrophenyl p-guanidinobenzoate. A thermodynamic and kinetic study.

Catalog

Books, media, physical & digital resources